- Belief BioMed announced BBM-H901 (Dalnacogene Ponparvovec Injection), China's first hemophilia B gene therapy, was officially approved in Macao, China
- Alphamab Oncology Announces the First Patient Dosed in a Phase III Clinical Study for Triple-Negative Breast Cancer of TROP2/HER3 Bispecific ADC JSKN016
- Talino Closes $7.5M Series A to Launch a Global Fintech Foundry and Modernize Cross-border Infrastructure
- Cirrus360 presents 5G-edge-cloud innovation for workflow automation for small and medium meat processors
- Notice of Annual General Meeting
- Aikido Receives the 2026 Global Application Security Posture Management Customer Value Leadership Recognition for Excellence in Developer-First Security Innovation
- Henlius Reports 2025 Results: Sustained Growth in Both Revenue and Profit, Advancing Innovation Validation and Global Operations
- KLN and HKFSD Sign MOU to Enhance International Rescue Mobilisation and Logistics
- Pony.ai and Chenqi Mobility Launch Joint Robotaxi Fleet with Initial Delivery of Over 100 Gen-7 Vehicles
-
Agoda's Top Picks for Unique Zipline Adventures in Asia
-
A NIGHT TO ROAR: LIONS RETURN HOME AFTER HISTORIC ASIAN CUP QUALIFICATION
-
H World Group Reports Strong Full-Year 2025 Results, Driven by Asset-light Growth
-
Why Red Velvet’s Irene Named Her New Album “Biggest Fan”
-
Why T.O.P First Solo Album ‘ANOTHER DIMENSION’ is a Major Strategic Shift
- Alphamab Oncology Appoints Mr. Fei Wang as Chief Financial Officer
- National Film Board of Canada brings Lavis and Szczerbowski's Oscar-winning The Girl Who Cried Pearls to audiences around the world
- Arcfra AECP 6.3 Breaks the 11M IOPS Barrier, Delivering Tier-1 All-Flash Performance and RPO=0 Resilience for Enterprise Cloud
허블 정보
Copyright © 2017 Huvle All Rights Reserved
admin@huvle.com